Results 11 to 20 of about 106,089 (259)

VPA DIGITAL AT YOUR FINGERTIPS

open access: yesVision Pan-America, 2018
VPA DIGITAL AT YOUR ...
Paulo E.C. Dantas
doaj   +1 more source

Erratum/VII World Cornea Congress

open access: yesVision Pan-America, 2015
Errata
Paulo E.C. Dantas
doaj   +1 more source

Advertisements

open access: yesVision Pan-America, 2013
RAYNER
Paulo E.C. Dantas
doaj   +1 more source

Obituary

open access: yesVision Pan-America, 2012
Dr.
Paulo E.C. Dantas
doaj   +1 more source

ALCON, NOVARTIS

open access: yesVision Pan-America, 2017
Advertisement
Paulo E.C. Dantas
doaj   +1 more source

PARD 2015 - A scientific party!

open access: yesVision Pan-America, 2015
PARD ...
Paulo E.C. Dantas
doaj   +1 more source

Abbott

open access: yesVision Pan-America, 2015
Abbott
Paulo E.C. Dantas
doaj   +1 more source

Cell Therapy of Corneal Diseases [PDF]

open access: yesCornea, 2016
Mesenchymal stem cells isolated from connective tissues are pluripotent and differentiate into phenotypes of connective tissue cell lineages (osteoblasts, chondrocytes, and adipocytes) in vitro and in vivo. They have been used to treat mouse models of connective tissue disease such as lumican-null (Lum) and mucopolysaccharidosis (Gusb) mice ...
Winston W-Y, Kao   +1 more
openaire   +2 more sources

Nanomedicine Approaches for Corneal Diseases [PDF]

open access: yesJournal of Functional Biomaterials, 2015
Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high concentration of the drugs applied in the eye ...
Shyam Chaurasia   +3 more
openaire   +3 more sources

XXXIV CONGRESO PANAMERICANO DE OFTALMOLOGIA

open access: yesVision Pan-America, 2017
CANCUN ...
Paulo E.C. Dantas
doaj   +1 more source

Home - About - Disclaimer - Privacy